“When my father, Dr. Gabriele Braglia, founded Helsinn in 1976, he had a simple pharmaceutical licensing business in mind. Almost 40 years later, over 500 committed employees and more than 65 commercial and marketing partners are helping us create a large portfolio of cancer-care therapies.
As we move forward, forging new partnerships, developing more innovative cancer-care solutions, and connecting directly with the cancer-care community, we will never forget our fundamental objective: to build better todays for every person affected by cancer”.
Managing Director and CEO
Helsinn Holding SA
Lugano, December 2013